4.3 Letter

Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19

Related references

Note: Only part of the references are listed.
Review Immunology

Pathological sequelae of long-haul COVID

Saurabh Mehandru et al.

Summary: This review examines the underlying pathophysiological mechanisms of post-COVID-19 syndromes, including persistent inflammation, induced autoimmunity, and putative viral reservoirs. The disease is called 'long-haul COVID' or 'post-COVID-19 syndrome', and clinical symptoms include fatigue, dyspnea, and neuropsychiatric syndromes.

NATURE IMMUNOLOGY (2022)

Article Immunology

Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers

Miguel Galan et al.

Summary: Long-COVID is a syndrome characterized by persistent symptoms and signs of COVID-19 even after weeks or months of infection. The underlying mechanisms are unclear, but immune dysregulation and certain clinical and demographic factors may contribute to the development of this condition. Accurate diagnostic biomarkers can help improve the management of Long-COVID patients.

FRONTIERS IN IMMUNOLOGY (2022)

Article Respiratory System

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge

Oriol Sibila et al.

Summary: The study found that about 60% of COVID-19 survivors had reduced DLCO 6 months after discharge, mainly in those over 60 years old, with a history of smoking, hypertension, severe COVID-19 experience, and persistent dyspnea after discharge. In addition, patients with reduced DLCO had higher levels of epithelial and endothelial markers.

RESPIRATORY RESEARCH (2022)

Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

Article Multidisciplinary Sciences

Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler et al.

Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.

NATURE (2021)

Letter Respiratory System

Lung Function sequelae in COVID-19 Patients 3 Months After Hospital Discharge

Oriol Sibila et al.

ARCHIVOS DE BRONCONEUMOLOGIA (2021)

Review Biochemistry & Molecular Biology

Post-acute COVID-19 syndrome

Ani Nalbandian et al.

Summary: SARS-CoV-2 is responsible for the COVID-19 pandemic, causing global healthcare crises. Recovery from COVID-19 may lead to persistent symptoms and long-term complications, prompting the need for multidisciplinary care and follow-up for survivors.

NATURE MEDICINE (2021)

Article Critical Care Medicine

Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses

Woo-Jung Song et al.

Summary: Cough is a common symptom of COVID-19 and can persist for weeks or even months after infection, leading to long-term effects known as post-COVID syndrome. Researchers hypothesize that neurotropic pathways may be responsible for cough hypersensitivity state after SARS-CoV-2 infection, and neuroinflammatory events in the brain could contribute to the development of post-COVID syndrome. There are gaps in understanding the mechanisms of acute and chronic COVID-19 associated cough and post-COVID syndrome, but potential ways to reduce the impact of COVID-19 by controlling cough are being considered.

LANCET RESPIRATORY MEDICINE (2021)

Article Multidisciplinary Sciences

More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

Sandra Lopez-Leon et al.

Summary: This study aimed to identify studies assessing the long-term effects of COVID-19, estimating that 80% of infected patients will develop one or more long-term symptoms, with the most common being fatigue, headache, attention disorder, hair loss, and dyspnea.

SCIENTIFIC REPORTS (2021)

Article Cell Biology

Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms

Michael J. Peluso et al.

Summary: In this study, 70 individuals with PCR-confirmed SARS-CoV-2 infection were longitudinally observed for T cell responses, inflammation markers, antibody levels, and neutralization capacity. The study found that T cell responses remain stable for up to 9 months and that CD4(+) T cell responses in the early stage correlate with the severity of infection. Pre-existing lung disease is independently associated with higher long-term CD8(+) T cell responses, and individuals with PASC showed a more rapid decline in specific CD8(+) T cell responses.

CELL REPORTS (2021)

Article Immunology

Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids

Jiufeng Sun et al.

EMERGING INFECTIOUS DISEASES (2020)

Article Critical Care Medicine

Standardization of Spirometry 2019 Update An Official American Thoracic Society and European Respiratory Society Technical Statement

Brian L. Graham et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Article Respiratory System

2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung

Brian L. Graham et al.

EUROPEAN RESPIRATORY JOURNAL (2017)